Cited by 270Pancreatic and Hepatic Oncology ResearchProtein Kinase Regulation and GTPase SignalingPancreatitis Pathology and Treatment

Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions

Open access
Liou, Geou-Yarh, Döppler, Heike, DelGiorno, Kathleen E., Zhang, Lizhi, Leitges, Michael, Crawford, Howard C., Murphy, Michael P., Storz, Peter·2016·Cell Reports

Abstract

The development of pancreatic cancer requires the acquisition of oncogenic KRas mutations and upregulation of growth factor signaling, but the relationship between these is not well established. Here, we show that mutant KRas alters mitochondrial metabolism in pancreatic acinar cells, resulting in increased generation of mitochondrial reactive oxygen species (mROS). Mitochondrial ROS then drives the dedifferentiation of acinar cells to a duct-like progenitor phenotype and progression to PanIN. This is mediated via the ROS-receptive kinase protein kinase D1 and the transcription factors NF-κB1 and NF-κB2, which upregulate expression of the epidermal growth factor, its ligands, and their sheddase ADAM17. In vivo, interception of KRas-mediated generation of mROS reduced the formation of pre-neoplastic lesions. Hence, our data provide insight into how oncogenic KRas interacts with growth factor signaling to induce the formation of pancreatic cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2016.02.029

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In mice, metabolic reprogramming in response to oncogenic KRas in pancreatic acinar cells promotes acinar-to-ductal metaplasia, a precursor to pancreatic ductal adenocarcinoma.

    “In mice, metabolic reprogramming in response to oncogenic KRas in pancreatic acinar cells promotes acinar-to-ductal metaplasia (ADM), a precursor to pancreatic ductal adenocarcinoma (PDAC) (19).”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [19]

  • Oncogenic KRas increases acetyl-CoA and ROS before ADM develops, and inhibiting these phenotypes blocks ADM.

    “Oncogenic KRas increases the levels of acetyl coenzyme A (CoA) and reactive oxygen species (ROS) before the development of ADM, and inhibiting these phenotypes blocks ADM (19, 20).”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [19]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liou, G.-Y., Döppler, H., DelGiorno, K. E., Zhang, L., Leitges, M., Crawford, H. C., Murphy, M. P., & Storz, P.
Affiliations
  • Mayo Clinic (US)
  • University of Oslo (NO)
  • MRC Mitochondrial Biology Unit (GB)
Venue
Cell Reports
Publisher
Elsevier BV
Published
2016-03
Volume
14
Issue
10
Pages
2325-2336
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2291790203
Cited by
270
References
44
Citations by year
2026: 19 · 2025: 24 · 2024: 22 · 2023: 36 · 2022: 41 · 2021: 34 · 2020: 30 · 2019: 20 · 2018: 13 · 2017: 22 · 2016: 9
FWCI
11.51
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Norges Forskningsråd
  • National Institutes of Health (197261, CA140182, CA159222, CA200572)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords
mutant KRAS, mitochondrial reactive oxygen species, mitochondrial oxidative stress, pancreatic acinar cells, EGFR signaling, pancreatic intraepithelial neoplasia, pancreatic precancerous lesions, protein kinase D1, NFKB1, NF-κB2, ADAM17, pancreatic cancer initiation, mitochondrial metabolism
MeSH terms
ADAM17 Protein, Animals, Cells, Cultured, Epidermal Growth Factor, Humans, Ligands, Mitochondria, Pancreatic Neoplasms, Precancerous Conditions, Protein Kinase C, Signal Transduction, Up-Regulation, Proto-Oncogene Proteins p21(ras), Mutagenesis, Site-Directed, Reactive Oxygen Species, Oxidative Stress, RNA Interference, Mice, NF-kappa B p52 Subunit, Acinar Cells, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review